TOKIMUS BIOTECHBIOTECHNOLOGY SOLUTIONS FROM AROUND THE WORLD

C O V ID -1 9 T e s t K i t s f o r N o r t h A m e r i c a

A B E T T E R A L T E R N A T I V E F O R C O V I D -1 9 T E S T I N G

T o k im u s B io t e c h w a s fo u n d e d b y a g ro u p o f m e d ic a l e x p e r t s a n d im p o r te rs d e d ic a te d to p ro v id in g fa ir ly -p r ic e d , q u a lit y d is e a s e te s t in g in N o r th A m e r ic a . R e c o g n iz in g th e u n m e t n e e d fo r fa s t a n d re lia b le C O V ID -1 9 te s t in g , To k im u s is im p o r t in g F D A /E U A -a p p ro v e d , a ff o rd a b le d ia g n o s t ic t e s t k it s f ro m le a d in g , h ig h -c a p a c it y m a n u fa c tu re rs in S o u th K o re a .

T H E T O K I M U S A D V A N T A G E

E X P E R T I S EA b a la n c e d t e a m w it h p a r t ic u la r e x p e r t i s e in d is e a s e , m e d ic in e , U .S im p o r t in g a n d in t e r n a t io n a l fi n a n c e .

A F F O R D A B I L I T Y F a i r p r ic in g t o h e lp c o m m u n it ie s a n d g o v e r n m e n t s m a n a g e t h e C O V ID -1 9 c r i s i s .

R E G U L A T O R Y A P P R O V A L S O u r p r o d u c t s a r e F D A a p p r o v e d u n d e r S e c t io n 5 6 4 (c ) o f t h e E m e rg e n c y U s e A u t h o r iz a t io n (E U A ) p u r s u a n t t o S e c t io n 5 6 4 o f t h e F e d e r a l F o o d , D r u g , a n d C o sm e t ic A c t . T e s t e d b y t h e N a t io n a l In s t i t u t e o f H e a lt h (N IH ). T h e t e s t s a r e le g a l ly a p p r o v e d fo r s a le in t h e U .S . (M D E L # 1 4 1 8 2 fo r e x p o r t in t o C a n a d a )

R E L I A B I L I T Y IS O 1 3 4 8 5 -c e r t ifi e d , h ig h -c a p a c it y m a n u fa c t u re r s k n o w n in t e r n a t io n a l ly f o r q u a l i t y a n d r e l ia b i l i t y .

C A P A C I T Y O u r d is t r ib u t o r s c a n p r o d u c e 5 0 0 ,0 0 0 k i t s p e r w e e k a n d c a n r a m p u p t o 1 ,0 0 0 ,0 0 0 p e r w e e k .

C O M M I T M E N T E x c lu s iv e D is t r ib u t o r s h ip f o r N o r t h A m e r ic a .

O U R P R O D U C T S

P o ly m e r a s e C h a i n R e a c t i o n (P C R ) T e s t T h ro u g h th ro a t o r n a s a l sw a b s , t h is t e s t d e te c t s t h e g e n e t ic in fo rm a t io n o f t h e v iru s , o r it s R N A . T h is w ill e x is t o n ly if t h e v iru s is t h e re a n d s o m e o n e is a c t iv e ly in fe c te d . S am p le s a re s e n t to c e n t ra liz e d la b s fo r a n a ly s is . G e n e ra lly t h e s e a re t h e m o s t re lia b le t e s t s . A c c e s s o r ie s in c lu d e V TM /Sw a b s a n d R N A e x t ra c t io n k it s . Tw o v e rs io n s a re a v a ila b le :A ) A Q -TO P 3 0 m in , s in g le g e n e B ) A ls o fo r U -TO P -2 h o u r, m u lt i-g e n e , 1 0 0% a c c u ra c y. Fu tu re a p p lic a t io n s (su b je c t to F D A a p p ro v a l) fo r u se in flu /re sp ira to ry t e s t in g . T h e S e a s u n P C R te s t k it s a re a p p ro v e d in 1 1 c o u n t r ie s .

A n t i b o d y T e s t O u r A n t ib o d y Te s t K it id e n t ifi e s p e o p le w h o h a v e p re v io u s ly b e e n in fe c te d w ith C O V ID -1 9 . T h is t e s t p ro v id e s a g o o d w a y to t ra c k th e s p re a d o f t h e c o ro n a v iru s t h ro u g h a p o p u la t io n , a n d it c a n id e n t ify p e o p le e x p o s e d to th e v iru s b u t w h o m a y n o t h a v e e x p e r ie n c e d s ym p to m s . A ls o , o n c e id e n t ifi e d a s h a v in g a n t ib o d ie s t h a t in d ic a te re c o v e r y , p la sm a f ro m th e s e in d iv id u a ls m a y b e u s e d to t re a t v e r y ill C O V ID -1 9 p a t ie n t s .

p .1

A n t ib o d y t e s t f ro m S h in J in M e d ic s

V T M (V ira l T ra n s p o r t M e d iu m ) sw a b s fo r t h e P C R t e s t s

S e a s u n B io m a te r ia ls ’ C O V ID -1 9 R T -P C R Te s t K it (R e v e r s e T ra n s c r ip t io n - P o ly m e ra s e C h a in R e a c t io n )

p . 2

O U R S U P P L I E R S

S e a s u n B i o m a t e r i a l sO p e ra t in g s in c e 2 0 1 2 , S e a s u n B io m a te r ia ls o f D a e je o n , S o u th K o re a is a n in v it ro d ia g n o s t ic c o m p a n y th a t d e v e lo p s m o le c u la r d ia g n o s t ic p la t fo rm s fo r in fe c t io u s d is e a s e s , c a n c e r a n d g e n e t ic a n d e p ig e n e t ic d is o rd e rs . T h e y h o ld a lic e n s e o f M e d ic a l D e v ic e M a n u fa c tu r in g g ra n te d b y th e K o re a n M in is t r y o f F o o d a n d D ru g S a fe t y a n d a re c e r t ifi e d b y th e U S C e n te rs fo r D is e a s e C o n t ro l a s a D N A te s t in g in s t it u t io n . F o r C O V ID -1 9 S e a s u n o ff e rs V iru s C o lle c t io n K it s , T O P TM V ira l D N A /R N A E x t ra c t io n K it s , A Q T O P TM C O V ID 1 9 D e te c t io n K it s a n d U T O P TM C O V ID 1 9 D e te c t io n K it s . T h e S e a s u n U T O P TM K it s w e re h ig h ly ra te d in a t h ird p a r t y b lin d s tu d y b y th e F D A . T h e m a n u fa c tu r in g fa c ilit y is IS O 1 3 4 8 5 c e r t ifi e d a n d th e c o m p a n y h o ld s a G o o d M a n u fa c tu r in g P ra c t ic e (G M P ) c e r t ifi c a te . F o r m o r e in fo rm a t io n v is i t w w w .s e a s u n b io .c o m

S h i n J i n M e d i c s I n c . In e x is te n c e s in c e 1 9 9 2 , S h in J in d e v e lo p s a n d m a n u fa c tu re s a w id e ra n g e o f d ia g n o s t ic k it s a n d in s t ru m e n t s a n d h a s b e c o m e a g lo b a l le a d e r fo r im m u n o d ia g n o s t ic (in c lu d in g C O V ID -1 9 a n t ib o d y te s t s ) a n d life s c ie n c e t e c h n o lo g y . S h in J in M e d ic s is a u th o r iz e d to s e ll it s C O V ID -1 9 A n t ib o d y te s t in g k it in t h e U n ite d S t a te s v ia t h e E m e rg e n c y U s e A u th o r iz a t io n (E U A ) b y th e U S F o o d a n d D ru g A d m in is t ra t io n a n d , is in p ro c e s s v ia a p p lic a t io n in C a n a d a fo r re g u la to r y c le a ra n c e s th e re , v ia H e a lth C a n a d a . T h e y a re k n o w n fo r t h e h ig h e s t q u a lit y d ia g n o s t ic re a g e n t s a n d in s t ru m e n t s . F D A -E U A p e r N o t ifi c a t io n . F o r m o r e in fo rm a t io n v is i t w w w .d ia k e y .c o m /h o m e p a g e

R a p iG E N I n c .B a s e d in G y e o n g g i-d o , R e p u b lic o f K o re a , R a p iG E N In c . h a s d e v e lo p e d a n d s u p p lie d a d v a n c e d d is e a s e te s t in g te c h n o lo g y w o r ld w id e s in c e 2 0 0 2 . R a p iG E N ’s B io c re d it S A R S C o V 2 A n t ig e n te s t re p re s e n t s t h e w o r ld ’s fi rs t c o m m e rc ia liz a t io n o f B la c k G o ld Pa r t ic le te c h n o lo g y (h ig h se n s it iv it y a n d sp e c ifi c ity ). T h e te s t m e a su re s a n t ig e n s (if t h e p a t ie n t is in fe c t io u s ) a n d b o a s t s h ig h s e n s it iv it y /s p e c ifi c it y , s im p lic it y a n d ra p id t e s t t im e tu rn a ro u n d (5 - 8 m in u te s ). F D A -E U A is a p p lie d fo r a n d p e n d in g . F o r m o r e in fo rm a t io n v is i t w w w .ra p ig e n -in c .c o m

G e n e S o lu t i o n C o . L t dF o u n d e d in 2 0 1 9 , G e n e S o lu t io n is a g lo b a l b io te c h n o lo g y c o m p a n y b a s e d in In c h e o n , S o u th K o re a . T h e c o m p a n y h a s e m e rg e d ra p id ly a s a le a d in g , in te rn a t io n a l su p p lie r o f C O V ID -1 9 sam p le c o lle c t io n k its . F o r m o re in fo rm a t io n v is it h t tp s ://g e n e s o lu t io n .w ix s it e .c o m /w e b s ite ? la n g =e n

C O V ID -1 9 T e s t K i t s f o r N o r t h A m e r i c a

t o k im u s b io t e c h .c o m

C O V ID -1 9 T e s t K i t s f o r N o r t h A m e r i c a

p . 3

K E Y M A N A G E M E N T

P a t r i c k R i g g s P re s id e n t a n d C E OIm p o r t /e x p o r t e n t re p re n e u r a n d fi n a n c ie r fo r o v e r 1 5 y e a rs a n d a fi n a n c e c o n su lta n t a n d s t ra te g y a d v is o r to m id d le m a rk e t c o m p a n ie s . A s Im p o r t m a n a g e r fo r a n in te rn a t io n a l t ra d in g c o m p a n y , h e d e v e lo p e d lo n g te rm re la t io n s h ip s w ith k e y A s ia n t ra d in g p a r tn e rs , w h ic h le d to th e s u p p lie r re la t io n s h ip s n o w b e n e fi t in g To k im u s B io te c h . P a t a t te n d e d U n iv e rs it y o f N o r th D a k o ta in 1 9 9 0 a n d c o m p le te d a n in d e p e n d e n t s tu d y p ro g ram re c e iv in g u n iv e rs it y c re d it s a t H a r v a rd B u s in e s s S c h o o l in 2 0 1 9 .

J a s o n L i u C PA , M BAC F O

B o rn in Ta iw a n , J a s o n re c e iv e d h is a c c o u n t in g d e g re e f ro m A le th e ia U n iv e rs it y in Ta iw a n , t h e n c o m p le te d h is M B A a t t h e U n iv e rs it y o f H o u s to n . D u e to h is c o n t in u e d t ie s to Ta iw a n a n d A s ia , J a s o n p ro v id e s v a lu a b le in s ig h t s in to th e b u s in e s s c u ltu re o f S E A s ia a s w e ll a s p ro v id in g m a n y c o n ta c t s . In h is c a re e r h e h a s b e e n in s tru m e n ta l in fin a n c in g b o th U S a n d fo re ig n e n tre p re n e u ria l c o m p an ie s .

G e r v a i s e W i lh e lm B S , (M e d ic a l Te c h n o lo g y ) M B A , M L S , PA (c a rd io v a s c u la r s u rg e r y ), R e g u la to r y a n d P ro d u c t A d v is o r

In a d d it io n to fo rm a l t ra in in g a n d s e v e ra l y e a rs ’ e x p e r ie n c e a s a la b o ra to r y s c ie n t is t , M s . W ilh le m is a v e te ra n fo u n d e r, d ire c to r a n d o ffi c e r o f fi v e life s c ie n c e c o m p a n ie s . In t h a t c a p a c it y s h e h ire d k e y e m p lo y e e s , e n g a g e d a n d in te ra c te d w ith le g a l a n d fi n a n c ia l c o n s u lt a n t s , g e n e ra te d in v e s tm e n t c a p it a l, in te ra c te d w ith th e b o a rd s o f d ire c to rs a n d a c t iv e ly p a r t ic ip a te d in m a rk e t in g e ff o r t s in a d d it io n to m a n a g in g d a y -to -d a y a ff a ir s .

M a r y B e t h H e n d e r s o n B S , M S a n d P h D (C h e m is t r y )J o in e d To k im u s a s C o n s u lt a n t fo r R e g u la to r y A ff a ir s a n d Q u a lit y S y s te m s . D r. H e n d e rs o n w o rk e d fo r m o re th a n 2 5 y e a rs w ith m e d ic a l d e v ic e a n d b io te c h n o lo g y c o m p a n ie s d e v e lo p in g re g u la to r y s t ra te g y a n d q u a lit y s y s te m s d e v e lo p m e n t in c o n fo rm it y w ith d o m e s t ic a n d in te rn a t io n a l re g u la t io n s . A s V ic e P re s id e n t o f R e g u la to r y A ff a ir s a n d Q u a lit y S y s te m s a t o n e o f t h e la rg e s t re g u la to r y c o n s u lt in g fi rm s in t h e n a t io n , M a r y w o rk e d w ith c lie n t s to d e v e lo p d o m e s t ic a n d in te rn a t io n a l re g u la to r y s t ra te g ie s a n d n e g o t ia te d s u c c e s s fu lly w ith th e F D A fo r p ro d u c t a p p ro v a ls .

D r . D a r r e l l Y . C a ld e r o n M D , FA C E P, M e d ic a l A d v is o rD r. C a ld e ro n , w h o is C O L A c e r t ifi e d , p ro v id e s c ru c ia l d ire c t io n a n d c o n su lta t io n fo r p a t ie n t t e s t in g s e r v ic e s , b a c k e d b y h is e x p e r t is e w ith m e d ic a l s t a ff , la b p e rs o n n e l a n d h o s p it a l v e n d o r m a t te rs . D r. C a ld e ro n is c u r re n t ly C h ie f M e d ic a l O ffi c e r fo r t h e H o u s to n M a rk e t a n d D ire c to r o f t h e E m e rg e n c y D e p a r tm e n t fo r F ir s t Te x a s H o s p it a l C y F a ir.

T o k im u s B i o t e c h , I n c . 1 2 G r e e n w a y P la z a S u i t e 1 1 0 0 H o u s t o n , T X 7 7 0 4 6

T 6 1 2 .8 5 0 .5 0 2 9 p a t r ig g s@ t o k im u s b io t e c h .c o m

“W e ’v e fo c u se d o u r su p p ly c h a in o n S o u th K o re a b e c a u se th e ir q u a lit y is e x c e p t io n a l a n d th e ir p r ic in g is fa ir.”

P a t r i c k R i g g s , P re s id e n t a n d C E O

t o k im u s b io t e c h .c o m

“T h e e v id e n c e m a ke s c le a r it is t im e fo r a p a ra d ig m sh if t o n te s t in g . It is t im e fo r th e fe d e ra l g o v e rn m e n t to ta k e s t ro n g le a d e rsh ip o n d ire c t in g o u r re so u rc e s to w a rd th is n ew (fre q u e n t te s t in g ) s t ra te g y.”

D r . A s h i s h K . J h a , Fa c u lt y D ire c to r o f th e H a r v a rd G lo b a l H e a lth In s t itu te